Xarelto 30-Day Starter Pack Kit
- RxCUI
- 1549683
- RxNorm name
- Xarelto 30-Day Starter Pack Kit
- Display name
- Xarelto 30-Day Starter Pack Kit
- Full name
- Xarelto 30-Day Starter Pack Kit
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:47
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Xarelto | RIVAROXABAN | Janssen Pharmaceuticals, Inc. | 10db92f9-2300-4a80-836b-673e1ae91610 | 2026-01-16 | Boxed warning, Warnings, Adverse reactions | 1549683 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 10db92f9-2300-4a80-836b-673e1ae91610 | Xarelto 30-Day Starter Pack Kit | SY | 64 | These highlights do not include all the information needed to use XARELTO safely and effectively. See full prescribing information for XARELTO. XARELTO ® (rivaroxaban) tablets, for oral use XARELTO ® (rivaroxaban) for oral suspension Initial U.S. Approval: 2011 | 20260116 |
| 10db92f9-2300-4a80-836b-673e1ae91610 | Xarelto Starter Pack, 30-Day | PSN | 64 | These highlights do not include all the information needed to use XARELTO safely and effectively. See full prescribing information for XARELTO. XARELTO ® (rivaroxaban) tablets, for oral use XARELTO ® (rivaroxaban) for oral suspension Initial U.S. Approval: 2011 | 20260116 |
| 10db92f9-2300-4a80-836b-673e1ae91610 | {42 (rivaroxaban 15 MG Oral Tablet [Xarelto]) / 9 (rivaroxaban 20 MG Oral Tablet [Xarelto]) } Pack [Xarelto Kit] | BPCK | 64 | These highlights do not include all the information needed to use XARELTO safely and effectively. See full prescribing information for XARELTO. XARELTO ® (rivaroxaban) tablets, for oral use XARELTO ® (rivaroxaban) for oral suspension Initial U.S. Approval: 2011 | 20260116 |